메뉴 건너뛰기




Volumn 169, Issue 3, 2013, Pages 502-518

The natural history of actinic keratosis: A systematic review

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

EID: 84883352148     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12420     Document Type: Review
Times cited : (279)

References (38)
  • 1
    • 0013187458 scopus 로고
    • Des hyperkeratosis circonscrites
    • Dubreuilh WA,. Des hyperkeratosis circonscrites. Ann Dermatol Venereol 1896; 27: 1158-64.
    • (1896) Ann Dermatol Venereol , vol.27 , pp. 1158-1164
    • Dubreuilh, W.A.1
  • 2
    • 0033936811 scopus 로고    scopus 로고
    • The nature of solar keratosis: A critical review in historical perspective
    • Heaphy MR Jr, Ackerman AB,. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol 2000; 43: 138-50.
    • (2000) J Am Acad Dermatol , vol.43 , pp. 138-150
    • Heaphy, Jr.M.R.1    Ackerman, A.B.2
  • 3
    • 33745010916 scopus 로고    scopus 로고
    • Solar (actinic) keratosis is squamous cell carcinoma
    • Ackerman AB, Mones JM,. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006; 155: 9-22.
    • (2006) Br J Dermatol , vol.155 , pp. 9-22
    • Ackerman, A.B.1    Mones, J.M.2
  • 4
    • 79960945313 scopus 로고    scopus 로고
    • Progression of actinic keratosis to squamous cell carcinoma revisited: Clinical and treatment implications
    • Feldman SR, Fleischer AB Jr,. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis 2011; 87: 201-7.
    • (2011) Cutis , vol.87 , pp. 201-207
    • Feldman, S.R.1    Fleischer, Jr.A.B.2
  • 5
    • 84870878749 scopus 로고    scopus 로고
    • The importance of early diagnosis and treatment of actinic keratosis
    • Rigel DS, Stein Gold LF,. The importance of early diagnosis and treatment of actinic keratosis. J Am Acad Dermatol 2013; 68: S20-7.
    • (2013) J Am Acad Dermatol , vol.68
    • Rigel, D.S.1    Stein Gold, L.F.2
  • 6
    • 0033928866 scopus 로고    scopus 로고
    • Histopathology of incipient intraepidermal squamous cell carcinoma ('actinic keratosis')
    • Cockerell CJ,. Histopathology of incipient intraepidermal squamous cell carcinoma ('actinic keratosis'). J Am Acad Dermatol 2000; 42: 11-7.
    • (2000) J Am Acad Dermatol , vol.42 , pp. 11-17
    • Cockerell, C.J.1
  • 7
    • 34247376606 scopus 로고    scopus 로고
    • Actinic keratosis is an early in situ squamous cell carcinoma: A proposal for reclassification
    • Röwert-Huber J, Patel MJ, Forschner T, et al,. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 2007; 156: 8-12.
    • (2007) Br J Dermatol , vol.156 , pp. 8-12
    • Röwert-Huber, J.1    Patel, M.J.2    Forschner, T.3
  • 8
    • 79959971790 scopus 로고    scopus 로고
    • Molecular discrimination of cutaneous squamous cell carcinoma from actinic keratosis and normal skin
    • Ra SH, Li X, Binder S,. Molecular discrimination of cutaneous squamous cell carcinoma from actinic keratosis and normal skin. Mod Pathol 2011; 24: 963-73.
    • (2011) Mod Pathol , vol.24 , pp. 963-973
    • Ra, S.H.1    Li, X.2    Binder, S.3
  • 9
    • 69449100622 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
    • Moher D, Liberati A, Tetzlaff J, et al,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
    • (2009) BMJ , vol.339
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3
  • 10
    • 0034523080 scopus 로고    scopus 로고
    • Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)- dl -ornithine
    • Alberts DS, Dorr RT, Einspahr JG, et al,. Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)- dl -ornithine. Cancer Epidemiol Biomarkers Prev 2000; 9: 1281-6.
    • (2000) Cancer Epidemiol Biomarkers Prev , vol.9 , pp. 1281-1286
    • Alberts, D.S.1    Dorr, R.T.2    Einspahr, J.G.3
  • 11
    • 0028213876 scopus 로고
    • Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses
    • Alirezai M, Dupuy P, Amblard P, et al,. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol 1994; 30: 447-51.
    • (1994) J Am Acad Dermatol , vol.30 , pp. 447-451
    • Alirezai, M.1    Dupuy, P.2    Amblard, P.3
  • 12
    • 66649122857 scopus 로고    scopus 로고
    • Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
    • Criscione VD, Weinstock MA, Naylor MF, et al,. Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 2009; 115: 2523-30.
    • (2009) Cancer , vol.115 , pp. 2523-2530
    • Criscione, V.D.1    Weinstock, M.A.2    Naylor, M.F.3
  • 13
    • 0344522708 scopus 로고    scopus 로고
    • A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses
    • Darlington S, Williams G, Neale R, et al,. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003; 139: 451-5.
    • (2003) Arch Dermatol , vol.139 , pp. 451-455
    • Darlington, S.1    Williams, G.2    Neale, R.3
  • 14
    • 78650315025 scopus 로고    scopus 로고
    • Chemoprevention of nonmelanoma skin cancer with celecoxib: A randomized, double-blind, placebo-controlled trial
    • Elmets CA, Viner JL, Pentland AP, et al,. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 2010; 102: 1835-44.
    • (2010) J Natl Cancer Inst , vol.102 , pp. 1835-1844
    • Elmets, C.A.1    Viner, J.L.2    Pentland, A.P.3
  • 15
    • 67549133535 scopus 로고    scopus 로고
    • Chemoprevention of human actinic keratoses by topical dl -alpha-tocopherol
    • Foote JA, Ranger-Moore JR, Einspahr JG, et al,. Chemoprevention of human actinic keratoses by topical dl -alpha-tocopherol. Cancer Prev Res (Phila) 2009; 2: 394-400.
    • (2009) Cancer Prev Res (Phila) , vol.2 , pp. 394-400
    • Foote, J.A.1    Ranger-Moore, J.R.2    Einspahr, J.G.3
  • 16
    • 0033874309 scopus 로고    scopus 로고
    • High incidence and regression rates of solar keratoses in a Queensland community
    • Frost C, Williams G, Green A,. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol 2000; 115: 273-7.
    • (2000) J Invest Dermatol , vol.115 , pp. 273-277
    • Frost, C.1    Williams, G.2    Green, A.3
  • 17
    • 0031764379 scopus 로고    scopus 로고
    • A clinicopathological study of the effects of topical retinyl propionate cream in skin photoageing
    • Green C, Orchard G, Cerio R, Hawk JL,. A clinicopathological study of the effects of topical retinyl propionate cream in skin photoageing. Clin Exp Dermatol 1998; 23: 162-7.
    • (1998) Clin Exp Dermatol , vol.23 , pp. 162-167
    • Green, C.1    Orchard, G.2    Cerio, R.3    Hawk, J.L.4
  • 18
    • 0029849441 scopus 로고    scopus 로고
    • Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study
    • Harvey I, Frankel S, Marks R, et al,. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer 1996; 74: 1302-7.
    • (1996) Br J Cancer , vol.74 , pp. 1302-1307
    • Harvey, I.1    Frankel, S.2    Marks, R.3
  • 19
    • 34447291575 scopus 로고    scopus 로고
    • Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head
    • Jorizzo J, Dinehart S, Matheson R, et al,. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol 2007; 57: 265-8.
    • (2007) J Am Acad Dermatol , vol.57 , pp. 265-268
    • Jorizzo, J.1    Dinehart, S.2    Matheson, R.3
  • 20
    • 17444394323 scopus 로고    scopus 로고
    • Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: Results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials
    • Korman N, Moy R, Ling M, et al,. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol 2005; 141: 467-73.
    • (2005) Arch Dermatol , vol.141 , pp. 467-473
    • Korman, N.1    Moy, R.2    Ling, M.3
  • 21
    • 0023022258 scopus 로고
    • Spontaneous remission of solar keratoses: The case for conservative management
    • Marks R, Foley P, Goodman G, et al,. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 1986; 115: 649-55.
    • (1986) Br J Dermatol , vol.115 , pp. 649-655
    • Marks, R.1    Foley, P.2    Goodman, G.3
  • 22
    • 0023818793 scopus 로고
    • Malignant transformation of solar keratoses to squamous cell carcinoma
    • Marks R, Rennie G, Selwood TS,. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1: 795-7.
    • (1988) Lancet , vol.1 , pp. 795-797
    • Marks, R.1    Rennie, G.2    Selwood, T.S.3
  • 23
    • 77951222947 scopus 로고    scopus 로고
    • Randomized, double-blinded, placebo-controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses
    • Moloney F, Vestergaard M, Radojkovic B, Damian D,. Randomized, double-blinded, placebo-controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses. Br J Dermatol 2010; 162: 1138-9.
    • (2010) Br J Dermatol , vol.162 , pp. 1138-1139
    • Moloney, F.1    Vestergaard, M.2    Radojkovic, B.3    Damian, D.4
  • 24
    • 84863219824 scopus 로고    scopus 로고
    • Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses
    • Stockfleth E, Zwingers T, Willers C,. Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses. Eur J Dermatol 2012; 22: 370-4.
    • (2012) Eur J Dermatol , vol.22 , pp. 370-374
    • Stockfleth, E.1    Zwingers, T.2    Willers, C.3
  • 25
    • 74349111518 scopus 로고    scopus 로고
    • Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data
    • Szeimies RM, Stockfleth E, Popp G, et al,. Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data. Br J Dermatol 2010; 162: 410-4.
    • (2010) Br J Dermatol , vol.162 , pp. 410-414
    • Szeimies, R.M.1    Stockfleth, E.2    Popp, G.3
  • 26
    • 4644304377 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology
    • Szeimies RM, Gerritsen MJ, Gupta G, et al,. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 2004; 51: 547-55.
    • (2004) J Am Acad Dermatol , vol.51 , pp. 547-555
    • Szeimies, R.M.1    Gerritsen, M.J.2    Gupta, G.3
  • 27
    • 0027517607 scopus 로고
    • Reduction of solar keratoses by regular sunscreen use
    • Thompson SC, Jolley D, Marks R,. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329: 1147-51.
    • (1993) N Engl J Med , vol.329 , pp. 1147-1151
    • Thompson, S.C.1    Jolley, D.2    Marks, R.3
  • 28
    • 36549087129 scopus 로고    scopus 로고
    • Topical immunomodulation under systemic immunosuppression: Results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients
    • Ulrich C, Bichel J, Euvrard S, et al,. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 2007; 157 (Suppl. 2): 25-31.
    • (2007) Br J Dermatol , vol.157 , Issue.SUPPL. 2 , pp. 25-31
    • Ulrich, C.1    Bichel, J.2    Euvrard, S.3
  • 29
    • 70349312806 scopus 로고    scopus 로고
    • Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: A 24 months, prospective, case-control study
    • Ulrich C, Jurgensen JS, Degen A, et al,. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009; 161 (Suppl. 3): 78-84.
    • (2009) Br J Dermatol , vol.161 , Issue.SUPPL. 3 , pp. 78-84
    • Ulrich, C.1    Jurgensen, J.S.2    Degen, A.3
  • 30
    • 33744729650 scopus 로고    scopus 로고
    • Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients
    • Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA,. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006; 86: 25-8.
    • (2006) Acta Derm Venereol , vol.86 , pp. 25-28
    • Wulf, H.C.1    Pavel, S.2    Stender, I.3    Bakker-Wensveen, C.A.4
  • 31
    • 84883394403 scopus 로고    scopus 로고
    • Actinic keratoses are intermittently present during the natural course of their disease
    • Cantrell W, Turnham JW, Andea AA, et al,. Actinic keratoses are intermittently present during the natural course of their disease. J Invest Dermatol 2009; 129: S53.
    • (2009) J Invest Dermatol , vol.129
    • Cantrell, W.1    Turnham, J.W.2    Andea, A.A.3
  • 32
    • 0038724496 scopus 로고    scopus 로고
    • Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: A randomized trial
    • Kang S, Goldfarb MT, Weiss JS, et al,. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial. J Am Acad Dermatol 2003; 49: 83-90.
    • (2003) J Am Acad Dermatol , vol.49 , pp. 83-90
    • Kang, S.1    Goldfarb, M.T.2    Weiss, J.S.3
  • 33
    • 57649220006 scopus 로고    scopus 로고
    • Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses
    • Zeichner JA, Stern DWK, Uliasz A, et al,. Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses. J Am Acad Dermatol 2009; 60: 59-62.
    • (2009) J Am Acad Dermatol , vol.60 , pp. 59-62
    • Zeichner, J.A.1    Stern, D.W.K.2    Uliasz, A.3
  • 34
    • 3142585264 scopus 로고    scopus 로고
    • Quantifying actinic keratosis: Assessing the evidence
    • Epstein E,. Quantifying actinic keratosis: assessing the evidence. Am J Clin Dermatol 2004; 5: 141-4.
    • (2004) Am J Clin Dermatol , vol.5 , pp. 141-144
    • Epstein, E.1
  • 35
    • 0034873607 scopus 로고    scopus 로고
    • Reliability of counting actinic keratoses before and after brief consensus discussion: The VA topical tretinoin chemoprevention (VATTC) trial
    • Weinstock MA, Bingham SF, Cole GW, et al,. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial. Arch Dermatol 2001; 137: 1055-8.
    • (2001) Arch Dermatol , vol.137 , pp. 1055-1058
    • Weinstock, M.A.1    Bingham, S.F.2    Cole, G.W.3
  • 36
    • 33846260745 scopus 로고    scopus 로고
    • Russell Localio A. Much ado about nothing: A comparison of the performance of meta-analytical methods with rare events
    • Bradburn MJ, Deeks JJ, Berlin JA,. Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 2007; 26: 53-77.
    • (2007) Stat Med , vol.26 , pp. 53-77
    • Bradburn, M.J.1    Deeks, J.J.2    Berlin, J.A.3
  • 37
    • 0033612873 scopus 로고    scopus 로고
    • Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial
    • Green A, Williams G, Neale R, et al,. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999; 354: 723-9.
    • (1999) Lancet , vol.354 , pp. 723-729
    • Green, A.1    Williams, G.2    Neale, R.3
  • 38
    • 64849091849 scopus 로고    scopus 로고
    • Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: Results of two randomized controlled phase III studies
    • Hauschild A, Stockfleth E, Popp G, et al,. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol 2009; 160: 1066-74.
    • (2009) Br J Dermatol , vol.160 , pp. 1066-1074
    • Hauschild, A.1    Stockfleth, E.2    Popp, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.